These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 14668948)

  • 21. Hypocretin/Orexin Receptor Pharmacology and Sleep Phases.
    Sun Y; Tisdale RK; Kilduff TS
    Front Neurol Neurosci; 2021; 45():22-37. PubMed ID: 34052813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.
    Ohno K; Sakurai T
    Front Neuroendocrinol; 2008 Jan; 29(1):70-87. PubMed ID: 17910982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypocretin/orexin: maintenance of wakefulness and a multiplicity of other roles.
    Kilduff TS
    Sleep Med Rev; 2005 Aug; 9(4):227-30. PubMed ID: 15998593
    [No Abstract]   [Full Text] [Related]  

  • 24. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action.
    España RA; Baldo BA; Kelley AE; Berridge CW
    Neuroscience; 2001; 106(4):699-715. PubMed ID: 11682157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orexins/hypocretins excite basal forebrain cholinergic neurones.
    Eggermann E; Serafin M; Bayer L; Machard D; Saint-Mleux B; Jones BE; Mühlethaler M
    Neuroscience; 2001; 108(2):177-81. PubMed ID: 11734353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypocretin (orexin) receptor subtypes differentially enhance acetylcholine release and activate g protein subtypes in rat pontine reticular formation.
    Bernard R; Lydic R; Baghdoyan HA
    J Pharmacol Exp Ther; 2006 Apr; 317(1):163-71. PubMed ID: 16352704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of orexins in regulation of feeding and wakefulness.
    Sakurai T
    Neuroreport; 2002 Jun; 13(8):987-95. PubMed ID: 12060794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypocretin and its emerging role as a target for treatment of sleep disorders.
    Cao M; Guilleminault C
    Curr Neurol Neurosci Rep; 2011 Apr; 11(2):227-34. PubMed ID: 21170610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative physiology of orexins and orexin receptors.
    Mieda M; Sakurai T
    CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):281-95. PubMed ID: 19689310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sleep-wake cycle, the hypocretin/orexin system and narcolepsy: advances from preclinical research to treatment.
    Arias-Carrión O; Bradbury M
    CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):232-4. PubMed ID: 19689304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comments to the editor concerning the paper entitled "Orexin-A regulates body temperature in coordination with arousal status" by Yoshimichi et al.
    Aronoff DM
    Exp Biol Med (Maywood); 2002 Jan; 227(1):1-2; discussion 3. PubMed ID: 11788776
    [No Abstract]   [Full Text] [Related]  

  • 32. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.
    Chemelli RM; Willie JT; Sinton CM; Elmquist JK; Scammell T; Lee C; Richardson JA; Williams SC; Xiong Y; Kisanuki Y; Fitch TE; Nakazato M; Hammer RE; Saper CB; Yanagisawa M
    Cell; 1999 Aug; 98(4):437-51. PubMed ID: 10481909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The neurotransmitter, hypocretin. An overview].
    Baumann C; Bassetti C
    Nervenarzt; 2004 Apr; 75(4):317-23. PubMed ID: 15088087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypocretins and adenosine in the regulation of sleep].
    Salín-Pascual RJ
    Rev Neurol; 2004 Aug 16-31; 39(4):354-8. PubMed ID: 15340896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hypocretin/orexin story.
    Samson WK; Resch ZT
    Trends Endocrinol Metab; 2000 Sep; 11(7):257-62. PubMed ID: 10920381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities.
    Yoshida Y; Fujiki N; Nakajima T; Ripley B; Matsumura H; Yoneda H; Mignot E; Nishino S
    Eur J Neurosci; 2001 Oct; 14(7):1075-81. PubMed ID: 11683899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypocretin/orexin and energy expenditure.
    Teske JA; Billington CJ; Kotz CM
    Acta Physiol (Oxf); 2010 Mar; 198(3):303-12. PubMed ID: 20070282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Narcolepsy: a key role for hypocretins (orexins).
    Siegel JM
    Cell; 1999 Aug; 98(4):409-12. PubMed ID: 10481905
    [No Abstract]   [Full Text] [Related]  

  • 40. The hypocretin/orexin system.
    Ebrahim IO; Howard RS; Kopelman MD; Sharief MK; Williams AJ
    J R Soc Med; 2002 May; 95(5):227-30. PubMed ID: 11983761
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.